Halozyme Therapeutics
HALO
New Fortress Energy
NFE
DexCom
DXCM
4
YETI Holdings
YETI
5
Teradata Corp
TDC
US Stock MarketDetailed Quotes
ERAS Erasca
- 1.225
- -0.025-2.00%
Close May 7 16:00 ET
347.03MMarket Cap-1.78P/E (TTM)
1.280High1.205Low2.81MVolume1.260Open1.250Pre Close3.46MTurnover1.40%Turnover RatioLossP/E (Static)283.29MShares3.45052wk High0.82P/B247.03MFloat Cap1.01052wk Low--Dividend TTM201.66MShs Float24.470Historical High--Div YieldTTM6.00%Amplitude1.010Historical Low1.229Avg Price1Lot Size
Erasca Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -8.10%-109.42M | 0.90%-24.56M | 7.05%-22.42M | -12.45%-29.18M | -26.15%-33.25M | 1.98%-101.22M | 6.01%-24.79M | -0.73%-24.12M | 4.38%-25.95M | -2.14%-26.36M |
| Net income from continuing operations | -29.28%-161.65M | -8.52%-32.23M | -2.76%-31.2M | -98.86%-63.2M | -5.48%-35.02M | 48.50%-125.04M | 78.04%-29.7M | 14.45%-30.36M | 10.75%-31.78M | 8.94%-33.2M |
| Depreciation and amortization | 1.96%3.81M | -11.68%832K | -10.52%842K | 18.64%1.13M | 11.63%998K | 41.31%3.73M | 0.96%942K | 22.05%941K | 78.84%955K | 121.84%894K |
| Other non cash items | --22.5M | --0 | --0 | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Change In working capital | 113.41%1.74M | 3,653.33%1.13M | 166.76%3.82M | 172.59%527K | -4,954.55%-3.74M | -94.85%813K | -99.12%30K | -74.94%1.43M | -125.12%-726K | -97.97%77K |
| -Change in prepaid assets | -355.27%-2.4M | -79.32%202K | 3.98%-1.76M | -129.63%-333K | -175.67%-507K | 126.00%939K | 8.56%977K | -3,205.08%-1.83M | 19.07%1.12M | 112.15%670K |
| -Change in payables and accrued expense | 252.62%4.86M | 282.98%1.3M | 70.09%5.95M | 129.29%603K | 23.59%-2.99M | -155.97%-3.19M | -158.37%-711K | -31.48%3.5M | -282.86%-2.06M | -122.81%-3.92M |
| -Change in other working capital | -123.91%-732K | -59.75%-377K | -58.47%-374K | 22.97%257K | -107.16%-238K | -77.66%3.06M | -118.55%-236K | -143.07%-236K | -74.51%209K | -69.95%3.32M |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -8.10%-109.42M | 0.90%-24.56M | 7.05%-22.42M | -12.45%-29.18M | -26.15%-33.25M | 1.98%-101.22M | 6.01%-24.79M | -0.73%-24.12M | 4.38%-25.95M | -2.14%-26.36M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -71.69%-156.62M | 397.62%22.62M | -5,561.98%-102.6M | 20.30%-86.61M | -32.23%9.97M | -28.33%-91.22M | 193.38%4.55M | 96.72%-1.81M | -1,082.32%-108.67M | 920.18%14.71M |
| Net PPE purchase and sale | 96.62%-60K | --0 | 97.92%-5K | 94.74%-13K | 96.52%-42K | 87.80%-1.78M | 90.51%-82K | 86.61%-240K | 94.58%-247K | 83.56%-1.21M |
| Net intangibles purchase and sale | -12.50%-22.5M | --0 | --0 | ---22.5M | --0 | -900.00%-20M | --0 | --0 | --0 | -900.00%-20M |
| Net investment purchase and sale | -93.04%-134.06M | 388.80%22.62M | -6,426.08%-102.59M | 40.88%-64.1M | -72.12%10.01M | -27.35%-69.45M | 215.59%4.63M | 97.06%-1.57M | -2,240.67%-108.42M | 376.27%35.92M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -71.69%-156.62M | 397.62%22.62M | -5,561.98%-102.6M | 20.30%-86.61M | -32.23%9.97M | -28.33%-91.22M | 193.38%4.55M | 96.72%-1.81M | -1,082.32%-108.67M | 920.18%14.71M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 18,486.64%240.7M | 75.66%801K | 301,285.71%21.1M | 32,545.30%211.87M | 3,687.43%6.93M | -98.68%1.3M | -99.53%456K | -98.36%7K | -34.58%649K | -60.22%183K |
| Net common stock issuance | --239.06M | --0 | --20.79M | --211.37M | --6.91M | --0 | --0 | --0 | --0 | --0 |
| Proceeds from stock option exercised by employees | 26.33%1.64M | 75.66%801K | 4,342.86%311K | -22.96%500K | -86.89%24K | -54.14%1.3M | -51.75%456K | -98.36%7K | -34.58%649K | -60.22%183K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 18,486.64%240.7M | 75.66%801K | 301,285.71%21.1M | 32,545.30%211.87M | 3,687.43%6.93M | -98.68%1.3M | -99.53%456K | -98.36%7K | -34.58%649K | -60.22%183K |
| Net cash flow | ||||||||||
| Beginning cash position | -67.16%93.48M | -38.82%69.29M | 24.44%173.21M | -71.76%77.13M | -67.16%93.48M | -21.13%284.63M | -48.44%113.27M | -53.36%139.2M | -18.15%273.16M | -21.13%284.63M |
| Current changes in cash | 86.74%-25.34M | 94.21%-1.15M | -300.84%-103.92M | 171.72%96.08M | -42.65%-16.35M | -150.61%-191.14M | -130.46%-19.79M | 67.08%-25.93M | -279.09%-133.97M | 57.77%-11.46M |
| End cash Position | -27.10%68.15M | -27.10%68.15M | -38.82%69.29M | 24.44%173.21M | -71.76%77.13M | -67.16%93.48M | -67.16%93.48M | -48.44%113.27M | -53.36%139.2M | -18.15%273.16M |
| Free cash flow | -7.31%-131.98M | 1.23%-24.56M | 7.95%-22.42M | -97.33%-51.7M | 30.00%-33.29M | -2.65%-122.99M | 8.69%-24.87M | 5.35%-24.36M | 17.36%-26.2M | -35.35%-47.56M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |
Market Insights
Discussing
FOMC holds rates amid heightened uncertainty: Where will US stocks head next?
🎙️Discussion 1. With the Fed highlighting "elevated uncertainty", are you prioritizing rate projections or near-term economic data for ma
Moo Live
Mar 20 02:25
FOMC Press Conference, March 19, 2025